Correlation of Systemic Inflammatory Status and Cardiac Myonecrosis in Patients Undergoing Percutaneoues Coronary

M K Mohsin1, M U Ahmed

  • 1Dr Md Khaled Mohsin, Senior Consultant, &Associate Professor, Cardiology, National Heart Foundation Hospitals & RI, Mirpur, Dhaka, Bangladesh.

Insights

Pre-procedural high-sensitivity C-reactive protein (hs-CRP) levels do not predict cardiac myonecrosis after percutaneous coronary intervention (PCI). This study found no correlation between pre-PCI hs-CRP and post-PCI myocardial injury markers.

Area of Science:

  • Cardiology
  • Biomarkers
  • Interventional Cardiology

Background:

  • High-sensitivity C-reactive protein (hs-CRP) is an inflammatory biomarker linked to cardiovascular events.
  • Pre-procedural hs-CRP levels may influence outcomes following percutaneous coronary intervention (PCI).
  • Previous studies suggest a link between pre-PCI CRP and PCI-induced cardiac myonecrosis.

Purpose of the Study:

  • To investigate the influence of pre-PCI hs-CRP levels on post-PCI cardiac myonecrosis.
  • To evaluate the role of procedural factors and medications in post-PCI myonecrosis.

Main Methods:

  • Prospective observational study at a tertiary referral hospital.
  • 38 patients with normal pre-procedural troponin T undergoing elective PCI were included.
  • hs-CRP, troponin T (TnT), and CKMBM levels were measured before and after PCI.

Main Results:

  • Elevated hs-CRP levels were common (>60%) before PCI and increased post-PCI (>65%).
  • Significant increases in post-PCI TnT and CKMBM were observed (p<0.05).
  • No significant correlation was found between pre-PCI hs-CRP and post-PCI TnT or CKMBM.

Conclusions:

  • Pre-PCI hs-CRP levels did not correlate with post-PCI cardiac myonecrosis.
  • Procedural parameters, age, and ongoing medications did not significantly influence cardiac myonecrosis.
  • The study suggests pre-PCI hs-CRP is not a reliable predictor of myocardial injury post-PCI.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
520
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
353
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
668
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
590